ArticleInternational journal of obesity (2005)2025

Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist.

Sophia Ramirez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.